Top Seven Weed Science Stories of 2013

Health
Biggest Weed Science Stories 2013
Photo by M. Martin Vicente

1) EPILEPSY

The FDA approves a new cannabis-based drug, Epidiolex, made by GW Pharmaceuticals for two separate trials involving children with intractable epilepsy.

2) LEUKEMIA

Six different non-psychoactive cannabinoids were shown to inhibit growth of leukemia cells at all stages of the cell cycle, demonstrating their anti-cancer action.

3) BRAIN CANCER

GW Pharmaceuticals announces first ever human trials of cannabis-based pharmaceutical spray, Sativex, as an add-on treatment for aggressive brain cancer.

4) NICOTINE ADDICTION

Small, placebo-controlled trial involving CBD administered via vaporizer show that drugs that alter the endocannabinoid system might be effective treatments for nicotine addiction.

5) CROHN'S DISEASE

Medical marijuana achieves ‘Complete Remission’ of Crohn's disease and other inflammatory bowel diseases. Cannabis sativa improved appetite and sleep with no significant side effects. 

6) PARKINSON'S

The first ever human study of medical marijuana for Parkinson’s this year showed a dramatic reduction in pain associated with the disease; the effect lasted for around 2 to 3 hours. 

7) OBESITY/DIABETES

Regular marijuana use lowered the risk of insulin resistance, increased the levels of "good" HDL cholesterol, and reduced fasting insulin levels, resulting in a smaller waist circumference.